#depopulationagenda
Climate vaccine developer ArkeaBio has raised $26.5 million in Series A funding, the company announced last week. ArkeaBio aims to fight climate change by vaccinating livestock
A vaccine being developed by the company is designed to prevent animals from releasing methane emissions
The Boston-based startup secured its first major investment in late 2022 from Breakthrough Energy Ventures, an investment fund founded by Killer Bill Gates
But human-targeted climate vaccines do appear to be in the works. Researchers at Gingko Bioworks, a biotech firm also backed by Killer Bill Gates & the CIA, have floated mRNA injections as a measure to mitigate the impact of global warming. The World Economic Forum has also expressed support for climate vaccines.